alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

**Certification ofChief Executive Officer ofAdvance America, Cash Advance Centers, Inc.Pursuant to 18 U.S.C. Section 1350(Adopted by Section 906 of the Sarbanes-Oxley Act of 2002)**

In connection withthe Quarterly Report on Form 10-Q of Advance America, Cash AdvanceCenters, Inc. (the “Company”) for the quarter ended September 30,2006, as filed with the Securities and Exchange Commission (the “Report”), I,Kenneth E. Compton, President and Chief Executive Officer, certify, pursuant to18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:

1.                The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934, and

2.                The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

|        |   | /s/ KENNETH E. COMPTON                                    |
|--------|--------|-----------------------------------------------------------|
|   |   | Kenneth E. Compton*President and Chief Executive Officer* |

 

November 9, 2006

61

----
Avril DEOKI, Appellant, v. WELLS FARGO BANK, N.A., as Trustee for Option One Mortgage Loan Trust 2007-FXD1, Appellee.

No. 4D18-3513

District Court of Appeal of Florida, Fourth District.

[March 13, 2019]

Avril Deoki, Sunrise, pro se.

No brief filed for appellee.

Per Curiam.

The court has reviewed appellant's initial brief and finds that no preliminary basis for reversal has been demonstrated. The appeal is therefore affirmed pursuant to Florida Rule of Appellate Procedure 9.315.

Gross, Conner and Klingensmith, JJ., concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Eunice Kennedy Shriver National Institute of Child Health and Human Development Special Emphasis Panel; the Road to Prevention of Stillbirth—Data Coordinating Center (UM2) Companion.                    

*Date:*                         March 28, 2025.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

Address: Eunice Kennedy Shriver National Institute  of Child Health and Human Development, 6710 B Rockledge Drive, Bethesda, MD 20892.

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Luis E. Dettin, Ph.D., Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH 6710B, Rockledge Drive, Rm. 2131B, Bethesda, MD 20892, (301) 827-8231,                         *luis_dettin@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: January 8, 2025. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2025-00605 Filed 1-13-25; 8:45 am]

BILLING CODE 4140-01-P
Joseph Andrew SYKES Jr., Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-167

District Court of Appeal of Florida, Second District.

Opinion filed February 15, 2019

Affirmed.
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

__________________ No. 95-40496 Summary Calendar

__________________ ERNESTO HINOJOSA, Petitioner-Appellant,

versus WAYNE SCOTT, DIRECTOR, TEXAS DEPARTMENT OF CRIMINAL JUSTICE, INSTITUTIONAL DIVISION, Respondent-Appellee.

- - - - - - - - - - Appeal from the United States District Court for the Southern District of Texas

USDC No. C-94-CV-337

- - - - - - - - - - January 23, 1996 Before HIGGINBOTHAM, DUHE’ and EMILIO M. GARZA, Circuit Judges. PER CURIAM: * This is an appeal from the dismissal of Ernesto Hinojosa's petition for the writ of habeas corpus. See U.S.C. § 2254. He argues that he received ineffective assistance by counsel's misinterpretation of the trial court's warning and discontinuance of cross-examination concerning the victim's violent reputation and character. Hinojosa's other ineffective-assistance claims which were raised in his petition are not raised in Hinojosa's appellate brief, and they are deemed abandoned on appeal. See Yohey v. Collins , 985 F.2d 222, 224-25 (5th Cir. 1993).No. 95-40496 -2- We have reviewed the arguments and the record. For essentially the same reasons as explained in the magistrate judge's report, which was adopted by the district court, we conclude Hinojosa failed to show the requisite deficient performance and prejudice. See Strickland v. Washington , 466 U.S. 668, 687 (1984).
AFFIRMED.
Stephen WILLIAMS and Magnolia Williams, Appellant/Petitioner(s), v. SAFEPOINT INSURANCE COMPANY, Appellee/Respondent(s).

CASE NO.: 2D19-0279

District Court of Appeal of Florida, Second District.

May 06, 2019

BY ORDER OF THE COURT:

Pursuant to the notice of voluntary dismissal filed herein, this appeal is dismissed.
# United States Court **of Appeals**  **f or the Fifth Circuit** 

**____________** No. 23

- 60615 Summary Calendar

**____________ Ken Ejimofor Ezeah,** 

Petitioner **,**

versus **Merrick Garland,** U.S. Attorney General **,** Respondent

**.**

**______________________________** Petition for Review of an Order of the Board of Immigration Appeals

Agency No. A204 048 674

**______________________________** Before **Higginbotham, Jones,** and **Oldham,** Circuit Judges

**. Per Curiam**  **:** ***** Ken Ejimofar Ezeah, a native and citizen of Nigeria , petitions for review of an order of the Board of Immigration Appeals (BIA) denying his motion to reopen. Motions to reopen are “particularly disfavored.” Nguhlefeh Njilefac v. Garland , 992 F.3d 362, 365 n.3 (5th Cir. 2021). Consequently, we review the BIA’s denial of such motions “under a highly

**_____________________**

* This opinion is not designated for publication. See **5th Cir**

**. R** 

**.** 47.5. United States Court of Appeals Fifth Circuit 

### FILED September 5, 2024 Lyle W. Cayce Clerk Case: 23-60615 Document: 92-1 Page: 1 Date Filed: 09/05/2024No. 23

- 60615

2 deferential abuse

- of

- discretion standard.” Ovalles v. Rosen , 984 F.3d 1120, 1123 (5th Cir. 2021) (internal quotation marks and citation omitted). Under this standard, we will affirm unless the agency’s decision is “capricious, racially invidious, utterly without foundation in the evidence, or otherwise so irrational that it is arbitrary rather than the result of any perceptible rational approach.” Nguhlefeh Njilefac , 992 F.3d at 365 (internal quotation marks and citation omitted). Ezeah has not made thi s showing. His equitable tolling argument fails because he has not made the necessary diligence showing. See Mejia v. Barr , 952 F.3d 255, 259 (5th Cir. 2020); Diaz v. Sessions , 894 F.3d 222, 226 (5th Cir. 2018). He shows no error in the BIA’s conclusion that his claim of ineffective assistance of counsel failed for want of compliance with Matter of Lozada , 19 I. & N. Dec. 637 (BIA 1988)

. See Hernandez

- Ortez v. Holder , 741 F.3d 644, 647 (5th Cir. 2014) ; Lara v. Trominski , 216 F.3d 487, 496 (5th Cir. 2000). He likew ise shows no error in the BIA’s conclusion that he failed to show prima facie eligibility for relief. See Parada

- Orellana v. Garland , 21 F.4th 887, 893 (5th Cir. 2022) ; 8 U.S.C. § 1229b(b)(2)(A)(iv). We lack jurisdiction to consider his challenges to the BIA’s decision not to sua sponte reopen his proceedings and its order dismissing his appeal. See Stone v. INS , 514 U.S. 386, 394

- 406 (1995) ; Qorane v. Barr , 919 F.3d 904, 911

- 12 (5th Cir. 2019)

. Finally, he has not shown exceptional circumstances meriting appointed counsel. See Ulmer v. Chancellor , 691 F.2d 209, 213 (5th Cir. 1982)

. The petition for review is **DENIED** in part and **DISMISSED** in part for want of jurisdiction. The motion for appointment of counsel is **DENIED**

. Case: 23-60615 Document: 92-1 Page: 2 Date Filed: 09/05/2024
Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 1 of 6 PageID 154
 

 Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 2 of 6 PageID 155
 

 Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 3 of 6 PageID 156
 

 Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 4 of 6 PageID 157
 

 Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 5 of 6 PageID 158
 

 Case 3:04-cv-02573-D Document 52 Filed 08/01/06 Page 6 of 6 PageID 159
<PAGE>

                                                                    EXHIBIT 31.1

I, Joseph Skeehan, certify that:

1. I have reviewed this quarterly report on Form 10-Q of JMG Exploration, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:

      (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      (b) Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

      (c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

      (a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

      (b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date Spetember 12, 2006             By: /s/ Joseph Skeehan
                                    Acting President and Chief Executive Officer
                                    (Principal Executive Officer)
```

[Federal Register Volume 90, Number 9 (Wednesday, January 15, 2025)]
[Notices]
[Page 3889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00844]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Dental & Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research; Special Grants Review Committee.
    Date: February 25-26, 2025.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Dental & Craniofacial Research, 
31 Center Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Aiwu Cheng, Ph.D., Scientific Review Officer, 
National Institute of Dental and Craniofacial Research, National 
Institutes of Health, 31 Center Drive, Bethesda, MD 20892, (301) 
594-4859, email: [email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

    Dated: January 10, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00844 Filed 1-14-25; 8:45 am]
BILLING CODE 4140-01-P
```
Exhibit 32.1



Certification Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the Quarterly Report of Biotel Inc. (the Company) on Form 10-Q for the period ended December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, in the capacities listed below, hereby certify, pursuant to 18U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Biotel Inc.Date:  February 12, 2009

        

        By:

        /s/ B. Steven SpringroseB. Steven SpringroseChief Executive Officerand President(principal executive officer)




Date:  February 12, 2009

        

        By:

        /s/ Judy E. NausJudy E. NausChief Financial Officer(principal financial officer)




A signed original of this written statement required by Section 906 has been provided to Biotel Inc. and will be retained by Biotel Inc. and furnished to the Securities and Exchange Commission or its staff upon request.







---
# C_2016222EN.01002701.xml

| 20.6.2016 | EN | Official Journal of the European Union | C 222/27 |
| --- | --- | --- | --- |

20.6.2016

EN

Official Journal of the European Union

C 222/27

---

Action brought on 22 April 2016 — L’Oréal v EUIPO — Guinot (MASTER PRECISE)

(Case T-181/16)

(2016/C 222/34)

Language in which the application was lodged: French

Parties

Applicant: L’Oréal (Paris, France) (represented by: T. de Haan and P. Péters, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Guinot SAS (Paris, France)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘MASTER PRECISE’ — Application for registration No 11 567 203

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 23 February 2016 in Case R 2911/2014-5

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to pay the costs, including those incurred by the applicant for the purposes of the proceedings before the Fifth Board of Appeal of EUIPO. |
| --- | --- |

—

order EUIPO to pay the costs, including those incurred by the applicant for the purposes of the proceedings before the Fifth Board of Appeal of EUIPO.

Plea in law

| — | Infringement of Article 8(1)(b) read in conjunction with Article 75 of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 8(1)(b) read in conjunction with Article 75 of Regulation No 207/2009.

---
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

RUTGER L. VAN ZANTEN, §

Plaintiff, §

§ Civil No. 3:04-CV-0783-K

v. §

§

COMMISSIONER OF SOCIAL §

SECURITY, §

Defendant. §

ORDER

After making an independent review of the pleadings, files and records in this

case, and the Findings, Conclusions, and Recommendation of the of the United States

Magistrate Judge, I am of the opinion that the Findings, Conclusions, and

Recommendation of the Magistrate Judge are correct and are adopted as the Findings

and Conclusions of the Court. 

It is therefore ORDERED that the Findings, Conclusions, and Recommendation

of the United States Magistrate Judge are adopted. Accordingly, Plaintiff’s motion for

summary judgment is hereby DENIED, and Defendant’s motion for summary judgment

is hereby GRANTED. Plaintiff’s Objections to the Findings, Conclusions, and

Recommendation of the of the United States Magistrate Judge, filed on April 2, 2007,

are OVERRULED.

SO ORDERED.

SIGNED: April 10 , 2007.

th

____________________________________

ED KINKEADE

UNITED STATES DISTRICT JUDGE

 

 Case 3:04-cv-00783-K-BH Document 28 Filed 04/10/07 Page 1 of 1 PageID 184
**EXHIBIT 32.1**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002***

 

In connection with theQuarterly Report of GeoPetro Resources Company (the “Company”) on Form 10-Qfor the period ending March 31, 2008 as filed with the Securities andExchange Commission on the date hereof (the “Report”), the undersigned, StuartJ. Doshi , Chief Executive Officer, and J. Chris Steinhauser, Chief FinancialOfficer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, tohis knowledge, that:

 

(1)      The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)      The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 
| Dated: May 13,  2008 | /s/ Stuart J. Doshi                 |
|---------------------------|-------------------------------------|
|                      | Stuart J. Doshi                     |
|                      | President, Chief  Executive Officer |
|                      | and Chairman of the  Board          |
|                      |                                |
| Dated: May 13,  2008 | /s/ J. Chris  Steinhauser           |
|                      | J. Chris Steinhauser                |
|                      | Chief Financial Officer             |

 

A signed original of thiswritten statement required by Section 906 has been provided to GeoPetroResources Company and will be retained by GeoPetro Resources Company andfurnished to the Securities and Exchange Commission or its staff upon request.

 

----

*                 This certification is being furnishedsolely to accompany the Report pursuant to 18 U.S.C. Section 1350 and isnot being filed for purposes of Section 18 of the Securities Exchange Actof 1934, as amended, and is not to be incorporated by reference into any filingof the Company, whether made before or after the date hereof, regardless of anygeneral incorporation language in such filing.

 

----
Jordan BRYANT v. State of Louisiana, DEPARTMENT OF HEALTH AND HOSPITALS, et al.

NO. 2019-C-0264

Supreme Court of Louisiana.

April 8, 2019

Denied.
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 90 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
                                 H. R. 90

To amend title XXVII of the Public Health Service Act to provide for a 
  definition of short-term limited duration insurance, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 3, 2025

Mr. Biggs of Arizona introduced the following bill; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To amend title XXVII of the Public Health Service Act to provide for a 
  definition of short-term limited duration insurance, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health Coverage Choice Act''.

SEC. 2. DEFINITION OF SHORT-TERM LIMITED DURATION INSURANCE.

    Section 2791(b) of the Public Health Service Act (42 U.S.C. 300gg-
91(b)) is amended by adding at the end the following new paragraph:
            ``(6) Short-term limited duration insurance.--The term 
        `short-term limited duration insurance' means health insurance 
        coverage provided under a contract with a health insurance 
        issuer that--
                    ``(A) has an expiration date specified in the 
                contract that is less than 12 months after the original 
                effective date of the contract; and
                    ``(B) has a duration of not more than 3 years 
                (taking into account renewals or extensions) after the 
                original effective date of the contract.''.
                                 <all>
```